Alan F. Schatzberg

Clinical Focus

• Psychiatry

Administrative Appointments

• Chair, Stanford University School of Medicine - Psychiatry and Behavioral Sciences (1991 - present)

Professional Education

• Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1975)
• Fellowship: Harvard Medical School, MA (1972)
• Residency: Massachusetts Mental Health Center, MA (1972)
• Internship: Lenox Hill Hospital, NY (1969)
• Medical Education: New York University School of Medicine, NY (1968)

Research Interests

Biological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.

Publications

• Prefrontal plasticity and stress inoculation-induced resilience. Katz M, Liu C, Schaer M, Parker KJ, Ottet MC, Epps A, Buckmaster CL, Bammer R, Moseley ME, Schatzberg AF, Eliez S, Lyons DM "Dev Neurosci" 2009 ; 4 (31) : 293-9
• The silver lining of recent effectiveness trials. Schatzberg AF, "World Psychiatry" 2009 ; 1 (8) : 30-2
• The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study. Buckley T, Duggal V, Schatzberg AF "J Clin Sleep Med" 2008 ; 3 (4) : 235-41
• Extended cognitive behavior therapy for cigarette smoking cessation. Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M "Addiction" 2008 ; 8 (103) : 1381-90
• The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Buckley TM, Mullen BC, Schatzberg AF "Psychoneuroendocrinology" 2007 Sep-Nov ; 8-10 (32) : 859-64